Dow Today: Visa (V) Leads The Day Higher, Johnson & Johnson (JNJ) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) closed up 104 points (+0.6%) at 16,207. During the day, 529.4 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 380.5 million. The NYSE advances/declines ratio closed at 1,890 issues advancing vs. 1,149 declining with 148 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component that led the way higher today was Visa (NYSE: V), which sported a $2.83 gain (+1.3%) bringing the stock to $226.19. This single gain lifted the Dow Jones Industrial Average by 21.42 points or roughly accounting for 20.6% of the Dow's overall gain. Volume for Visa ended the day at 2.7 million shares traded vs. an average daily trading volume of 3.3 million shares.

Visa has a market cap of $112.69 billion and is part of the financial sector and financial services industry. Shares are up 0.3% year to date as of Friday's close. The stock's dividend yield sits at 0.7%.

Visa Inc., a payments technology company, operates as a retail electronic payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.

TheStreet Ratings rates Visa as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

Holding the Dow back today was Johnson & Johnson (NYSE: JNJ), which lagged the broader Dow index with a 41-cent decline (-0.5%) bringing the stock to $91.11. Volume for Johnson & Johnson ended the day at 7.3 million shares traded vs. an average daily trading volume of 8.2 million shares.

Johnson & Johnson has a market cap of $260.64 billion and is part of the health care sector and drugs industry. Shares are up 0.9% year to date as of Friday's close. The stock's dividend yield sits at 2.9%.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Sneaky Rally; Wells Fargo Needs Outside Help -- Jim Cramer's Top Thoughts

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Cramer: Fantasy Shmantasy -- Let's Get Real With These Stock Picks

Visa, MasterCard, Discover Offer Secured Credit Cards, a Tool for College Kids

Cognizant Technology, Advanced Micro Devices: 'Mad Money' Lightning Round